Suchergebnisse - (Person:"Mo, Hongnan")

PubPharm (6)

1

Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer : A phase II trial

enthalten in: Breast (Edinburgh, Scotland) | 2023

von He, M. | Liu, J. | Wang, Z. | +11

2

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer : A nation-wide multicenter study

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Zhai, J. | Sun, X. | Zhao, F. | +8

3

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer : A study of the National Cancer Center, China

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Li, Y. | Mo, H. | Guan, X. | +14

4

Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China

enthalten in: Breast (Edinburgh, Scotland) | 2021

von Li, Y. | Li, Q. | Mo, H. | +16

5

Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Mo, H. | Wang, X. | Ma, F. | +7

6

Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Lin, S. | Mo, H. | Li, Y. | +14

1
[1]